Urinom MR is a modified-release (MR) formulation of Tamsulosin Hydrochloride 0.4 mg manufactured by Opsonin Pharma Ltd. in Bangladesh. It is primarily prescribed for the treatment of Benign Prostatic Hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can cause urinary symptoms.